A lot has been at stake in the US midterm elections. And a lot of questions remain. On November 14, Vox politics and policy reporters Li Zhou and Christian Paz answered your questions about the ...
Li brings a wealth of technical and strategic expertise in T-cell engineering, which will be of great value to TxCell as we develop novel and next-generation Treg-based therapies.” “ This is a very ...
TxCell (EPA:TXCL) has put a former Novartis ($NVS) researcher in charge of its CAR-Treg programs. Li Zhou spent more than six years working on CAR-T therapies at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback